Recombinant Salmonella Paratyphi A UbiB is a 546-amino acid protein (UniProt ID: Q5PKP2) expressed in E. coli with an N-terminal His tag . Key features include:
The full-length sequence (1–546 aa) includes conserved domains for ubiquinone biosynthesis and a variable central region critical for enzymatic activity .
UbiB is essential for aerobic respiration in Salmonella spp., catalyzing early steps in ubiquinone (Q8) biosynthesis . Key findings:
Genetic Knockout Studies: ubiB mutants exhibit impaired Q8 production, leading to respiratory defects under aerobic conditions .
Virulence Link: UbiB is required for intracellular proliferation in macrophages, directly linking Q8 biosynthesis to bacterial pathogenesis .
Structural Insights: The C-terminal 50–63 amino acids are critical for function, restoring 17% of wild-type Q8 levels in complementation assays .
Antigen Specificity: UbiB’s conserved epitopes make it a candidate for species-specific serodiagnostics .
Vaccine Components: Engineered outer membrane vesicles (GMMA) displaying UbiB and O:2 antigen induced bactericidal antibodies in mice, supporting its use in bivalent vaccines .
Paratype Tool: A SNP-based genotyping framework identified ubiB as a conserved marker across 18 Salmonella Paratyphi A genotypes, aiding global genomic tracking .
Antimicrobial Resistance (AMR): Genotype 2.3 ubiB variants correlate with IncHI1 plasmids carrying resistance genes (e.g., bla CTX-M-15) .
Structural Mutations: Mutations in the O2-polysaccharide locus near ubiB impact vaccine efficacy, highlighting its role in antigenic variation .
Oxygen-Independent Pathways: UbiB works with UbiJ/UbiT in a novel O2-independent hydroxylation pathway, expanding its role beyond aerobic conditions .
KEGG: spt:SPA3813
UbiB is a probable ubiquinone biosynthesis protein in Salmonella paratyphi A that participates in the synthesis of ubiquinone (UQ, also called coenzyme Q). In bacterial systems like S. paratyphi A, UbiB is one of the essential components in the UQ biosynthetic pathway. Evidence suggests it serves as an accessory protein rather than having direct enzymatic activity.
Methodological approach: To study UbiB function, researchers typically create knockout mutants (ΔubiB) in S. paratyphi A and analyze changes in ubiquinone levels using HPLC analysis coupled to electrochemical detection (ECD). Complementation studies with plasmid-expressed UbiB can confirm phenotype rescue.
UbiB's role in ubiquinone biosynthesis makes it critical for bacterial bioenergetics and electron transport. In S. enterica (closely related to S. paratyphi A), disruption of ubiquinone biosynthesis through mutations in biosynthetic proteins has been shown to reduce virulence and intracellular survival. Research has demonstrated that defects in ubiquinone biosynthesis genes, including ubiB, impair the ability of Salmonella to proliferate in macrophages and reduce virulence in mouse models .
Methodological approach: Researchers can assess the impact of UbiB on pathogenesis using macrophage infection assays, comparing survival rates of wild-type and ΔubiB mutants. In vivo virulence can be evaluated in mouse models by measuring bacterial loads in tissues after infection.
For in vitro studies, recombinant UbiB can be expressed in E. coli expression systems. Based on related Ubi proteins, several approaches are recommended:
Expression systems:
E. coli BL21(DE3) with pACYCDuet-1 plasmid has been successfully used for related Ubi proteins
IPTG-inducible systems with controlled temperature (typically 25-30°C) to enhance solubility
Purification techniques:
Affinity chromatography using His6-tagged constructs
Size exclusion chromatography to obtain pure protein
Multi-angle light scattering (SEC-MALS) to determine oligomeric state
For functional studies, S. paratyphi A challenge models and macrophage infection models are most relevant .
Based on studies of related proteins in the ubiquinone biosynthesis pathway, UbiB likely functions as part of a multi-protein complex. Research on UbiK, another ubiquinone biosynthesis accessory factor, has demonstrated interactions with multiple Ubi proteins, including UbiB . These interactions were confirmed through bacterial two-hybrid (BACTH) reporter systems.
Interaction data from related systems:
| Protein | Interacts with UbiB? | Verification method |
|---|---|---|
| UbiK | Yes | BACTH system |
| UbiJ | Indirect (via UbiK) | Pulldown assays |
| UbiE | Unknown for UbiB | Requires investigation |
| UbiF | Unknown for UbiB | Requires investigation |
| UbiG | Unknown for UbiB | Requires investigation |
Methodological approach: Researchers studying UbiB interactions should employ multiple complementary techniques:
Bacterial two-hybrid systems to screen for potential interactions
Co-immunoprecipitation with tagged UbiB to pull down interaction partners
Pulldown assays with MBP-tagged UbiB as bait
Surface plasmon resonance or isothermal titration calorimetry for quantitative binding parameters
Evidence from related ubiquinone biosynthesis proteins indicates condition-specific requirements. For example, UbiK and UbiJ are dispensable for UQ biosynthesis under anaerobiosis, even though they are expressed in the absence of oxygen . Since ubiquinone functions primarily in aerobic respiration, UbiB's role may be similarly condition-dependent.
Methodological approach: To investigate this question:
Perform RNA-seq or qPCR analysis of ubiB expression under aerobic vs. anaerobic conditions
Measure ubiquinone levels in wild-type and ΔubiB strains under both conditions using HPLC-ECD
Conduct growth experiments comparing ΔubiB mutant fitness in aerobic vs. anaerobic environments
Use promoter-reporter fusions (e.g., ubiB-lacZ) to visualize expression patterns under different oxygen tensions
While specific structural data for S. paratyphi A UbiB is limited, computational analysis suggests it likely belongs to the protein kinase-like superfamily with an ABC1 domain. The structure-function relationship could be investigated through:
Methodological approach:
Homology modeling based on related structures
Site-directed mutagenesis of predicted active site or protein interaction domains
X-ray crystallography or cryo-EM of purified recombinant UbiB
Hydrogen-deuterium exchange mass spectrometry to identify flexible regions and protein interaction surfaces
Based on successful approaches with related proteins, researchers should consider:
Expression optimization:
Test multiple E. coli strains (BL21, Rosetta, Arctic Express)
Vary induction conditions (IPTG concentration, temperature, duration)
Try fusion tags (His6, MBP, SUMO) to improve solubility
Consider codon optimization for bacterial expression
Purification strategy:
Affinity chromatography (Ni-NTA for His-tagged proteins)
Ion exchange chromatography to remove contaminants
Size exclusion chromatography for final polishing
Validate purity by SDS-PAGE and Western blotting
Confirm identity by mass spectrometry
For functional characterization, ensure the removal of the fusion tag does not affect protein activity and verify proper folding using circular dichroism spectroscopy.
Several approaches for creating ubiB knockouts can be considered:
Lambda Red recombination method:
Amplify an antibiotic resistance cassette with flanking homology to ubiB
Transform into S. paratyphi A expressing Lambda Red recombinase
Select for antibiotic-resistant colonies
Verify deletion by PCR and sequencing
CRISPR-Cas9 method:
Design guide RNAs targeting ubiB
Clone into CRISPR-Cas9 plasmid with homology repair template
Transform into S. paratyphi A
Select and verify deletions
Phenotypic analysis:
Compare growth rates in minimal vs. rich media
Measure ubiquinone levels by HPLC-ECD
Assess bacterial survival under oxidative stress
Test complementation with wild-type ubiB gene
Quantitative assays for ubiquinone:
HPLC coupled to electrochemical detection (HPLC-ECD) - The gold standard for quantifying ubiquinone levels in bacterial extracts
Mass spectrometry for detailed profiling of ubiquinone and intermediates
UV-visible spectroscopy (275 nm) for preliminary detection
Functional assays:
Bacterial growth under different electron acceptor conditions
Oxygen consumption rate measurements
Membrane potential assays using fluorescent dyes
ATP production measurements
Biosynthetic intermediate analysis:
Monitor accumulation of octaprenylphenol (OPP) or other intermediates by HPLC and mass spectrometry
In the absence of functional UbiB, S. paratyphi A likely accumulates early intermediates of the UQ biosynthetic pathway, similar to what has been observed with ubiK mutants
UbiB, being involved in ubiquinone biosynthesis, likely associates with membranes, presenting specific challenges:
Solubility optimization strategies:
Use mild detergents during purification (DDM, LDAO, or Triton X-100)
Test different detergent concentrations and buffer compositions
Consider amphipols or nanodiscs for maintaining native environment
Explore membrane scaffold proteins (MSPs) for reconstitution studies
Alternative approaches:
Domain-based studies of soluble regions
Cell-free expression systems
In silico modeling combined with targeted mutagenesis
Split-protein complementation assays for interaction studies
S. paratyphi A causes paratyphoid fever, a significant global health concern with rising antimicrobial resistance . Understanding UbiB's role can provide insights into:
Metabolic adaptations during infection:
Measure ubiquinone levels in bacteria isolated from infection models
Compare metabolite profiles of wild-type vs. ΔubiB mutants during infection
Analyze gene expression changes in response to host environments
Potential as antimicrobial target:
Screen for small molecule inhibitors of UbiB function
Test synergy between UbiB inhibitors and existing antibiotics
Evaluate resistance development potential
Vaccine development implications:
Systems biology offers powerful approaches to contextualizing UbiB function:
Multi-omics integration:
Combine transcriptomics, proteomics, and metabolomics data from wild-type and ΔubiB strains
Map flux changes in central metabolism when UbiB function is disrupted
Identify compensatory pathways activated in UbiB mutants
Network analysis:
Construct protein-protein interaction networks centered on UbiB
Identify genetic interactions through synthetic lethality screens
Model metabolic consequences of UbiB disruption using flux balance analysis
Proposed experimental workflow:
Generate comprehensive -omics datasets from defined conditions
Develop computational models of ubiquinone biosynthesis
Validate model predictions through targeted experiments
Iterate between modeling and experimental validation
The increasing prevalence of antimicrobial resistance in S. paratyphi A (particularly in South Asia ) necessitates new therapeutic approaches. UbiB represents a potential target based on:
Essential metabolic function: Disruption of ubiquinone biosynthesis affects bacterial bioenergetics
Virulence connection: Related ubi genes are implicated in Salmonella virulence
Limited host toxicity potential: Structural differences from human homologs could allow selective targeting
Research strategy:
Perform high-throughput screening for UbiB inhibitors
Evaluate hit compounds in bacterial growth and infection models
Optimize lead compounds for potency and selectivity
Assess resistance development potential
S. paratyphi A encounters various host environments during infection. UbiB's role in ubiquinone biosynthesis may be particularly important for:
Adaptation to oxygen-limited environments: Host tissues often have reduced oxygen tension
Response to oxidative stress: Phagocyte-generated reactive oxygen species require metabolic adaptation
Nutrient limitation: Host-imposed nutrient restriction may affect ubiquinone-dependent metabolism
Experimental approaches:
Compare transcription of ubiB under various in vitro conditions mimicking host environments
Analyze metabolite profiles in wild-type vs. ΔubiB strains under infection-relevant conditions
Use tissue culture and animal models to assess the impact of UbiB on bacterial adaptation during infection stages
Apply metabolomics approaches similar to those used to distinguish S. Typhi and S. Paratyphi A infections
| Mutant | UQ₈ Content (% of WT) | Intermediates Accumulated | Growth Phenotype (Aerobic) | Growth Phenotype (Anaerobic) | Virulence Impact |
|---|---|---|---|---|---|
| ΔubiK | 18% | Octaprenylphenol (OPP) | No defect in LB | Normal | Reduced proliferation in macrophages, reduced virulence in mice |
| ΔubiJ | Significantly reduced | Octaprenylphenol (OPP) | Defect | Normal | Reduced virulence |
| ΔubiB* | Requires investigation | Likely early intermediates | Requires investigation | Likely normal | Requires investigation |
*Based on related Ubi proteins; specific data for UbiB needs further investigation
Data derived from references
| Challenge Dose (CFU) | Attack Rate | Time to Bacteremia (Median) | Duration of Bacteremia (Median) | Clinical Manifestations |
|---|---|---|---|---|
| 1-5 × 10³ | 60% | 5.2 days | 4.1 days | Limited symptoms, high rates of subclinical bacteremia (55%) |
| 0.5-1 × 10³ | 40% | 7.0 days | 1.0 day | Even more limited symptoms |
| Protein | Interacts with UbiK | Evidence Method | Potential UbiB Interaction |
|---|---|---|---|
| UbiB | Yes | BACTH system | N/A (self) |
| UbiE | Yes | BACTH system | Requires investigation |
| UbiF | Yes | BACTH system | Requires investigation |
| UbiG | Yes | BACTH system | Requires investigation |
| UbiH | Yes | BACTH system | Requires investigation |
| UbiI | Yes | BACTH system | Requires investigation |
| UbiJ | Yes | BACTH system, co-purification, pulldown | Potential indirect interaction via UbiK |
| UbiX | Yes | BACTH system | Requires investigation |